Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
- PMID: 8504413
Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
Abstract
The MDM2 (murine double minute 2) gene has recently been shown to code for a cellular protein that can complex the p53 tumor suppressor gene product and inhibit its function. We studied a series of 157 primary brain tumors and report here that the MDM2 gene is amplified and overexpressed in 8-10% of glioblastomas and anaplastic astrocytomas. Thus, MDM2 represents the second most frequently amplified gene after the epidermal growth factor receptor gene in these tumor types. Sequencing of the p53 transcripts in the cases with MDM2 amplification revealed no mutations and restriction fragment length polymorphism analysis showed, with one exception, no losses of alleles on chromosome 17. Our results indicate that amplification and overexpression of MDM2 may be an alternative molecular mechanism by which a subset of human malignant gliomas escapes from p53-regulated growth control.
Similar articles
-
Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.Cancer Res. 1999 Dec 15;59(24):6091-6. Cancer Res. 1999. PMID: 10626796
-
Accumulation of wild type p53 protein in human astrocytomas.Cancer Res. 1993 Aug 1;53(15):3465-7. Cancer Res. 1993. PMID: 8339248
-
Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1774-83. doi: 10.1158/1055-9965.EPI-05-0089. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030116
-
Overexpression of the MDM2 oncogene in leukemia and lymphoma.Leuk Lymphoma. 1996 May;21(5-6):391-7, color plates XVI following 5. doi: 10.3109/10428199609093436. Leuk Lymphoma. 1996. PMID: 9172803 Review.
-
[Tumorogenesis and mdm2 protein].Rev Med Chil. 2000 May;128(5):539-46. Rev Med Chil. 2000. PMID: 11008360 Review. Spanish.
Cited by
-
MDM-2 protein expression in nasopharyngeal carcinomas. Comparative study with p53 protein expression.Clin Mol Pathol. 1995 Dec;48(6):M322-5. doi: 10.1136/mp.48.6.m322. Clin Mol Pathol. 1995. PMID: 16696032 Free PMC article.
-
Genetics of brain neoplasms.Curr Neurol Neurosci Rep. 2001 May;1(3):217-24. doi: 10.1007/s11910-001-0021-y. Curr Neurol Neurosci Rep. 2001. PMID: 11898521 Review.
-
Techniques to assess the proliferative potential of brain tumors.J Neurooncol. 2005 Aug;74(1):19-30. doi: 10.1007/s11060-004-5758-0. J Neurooncol. 2005. PMID: 16078103 Review.
-
An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.Cancer Cell. 2010 Sep 14;18(3):231-43. doi: 10.1016/j.ccr.2010.08.007. Cancer Cell. 2010. PMID: 20832751 Free PMC article.
-
Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma.Cells. 2022 Aug 15;11(16):2530. doi: 10.3390/cells11162530. Cells. 2022. PMID: 36010607 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous